However, as we showed, metastatic nodal seminoma cells were strongly positive for SMARCB1 by IHC, suggesting that loss of SMARCB1 in the STM chondrosarcoma represents an acquired genetic or epigenetic phenomenon rather than a germline event. Here, SMARCB1 is linked to seminoma.